A summary of recent works.
Our goal is a vaccine that prevents breast cancer before a first diagnosis. This summary maps the evidence we need, the data worth collecting and the collaborations that could make that research possible.
· 12 pages · 13 sources
AI-assisted literature summary. Not peer reviewed or medical advice.
Connect normal, high-risk and precursor tissue to molecular and HLA-presentation evidence. A tumor-only dataset misses the earlier window.
Link candidate antigens to functional immunity and normal-tissue safety, including physiological context and negative results.
Track first diagnoses, confirmed cancer-free follow-up and harms. Immune activity alone does not establish clinical benefit.
Primary-prevention research aims, not demonstrated protection in people or a Tesserie partnership.
Institutional announcement on safety and immune responses; not proof of preventing a first breast cancer.
Adjuvant clinical study; not randomized proof of reduced recurrence and not a primary-prevention trial.
Human observations and mouse experiments inform tissue immunity; not a preventive-vaccine trial or reproductive advice.
Antigen-presentation study, not a vaccine efficacy trial.